Horizon Discovery (LSE: HZD) (“Horizon” or the “Company”), a global leader in the application of gene editing and gene modulation to deliver inspired cell solutions, today announced the introduction ...
The company has developed a suite of functional genomic screening technologies, including a CRISPR-Cas9 platform. Horizon’s aim is to help its partners to identify, evaluate and validate targets ...
The GES Core expertly enables all aspects of state-of-the-art technologies in RNA interference and CRISPR-Cas9 mediated ... state-of-the-art automated arrayed 2D/3D laser line confocal imaging using ...
Horizon Discovery has announced the addition of an arrayed CRISPR knockout screening service for primary human B cells to its cell-based screening services. Horizon Discovery Group and Pharmahungary ...
"Our research interest is to identify these genes in order to better treat diseases." CRISPR screening methods can be used to systematically examine genes for their function in cells. "CRISPR is ...
CombiningTvDAO-based surrogate selection marker withthe CRISPR/Cas9 system enables the selection ofCas9-free and multigene CRISPR mutants. Disclaimer: AAAS and EurekAlert! are not responsible for ...
genetic engineering, CRISPR techniques and automation to improve the scale, robustness, cost and quality of functional genomics screens.
Through genome-wide CRISPR-Cas9 screening and RNA sequencing, we show that remdesivir treatment leads to a repression of mitochondrial respiratory activity, and we identify five genes whose loss ...